Yahoo Web Search

Search results

    • TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds

      Morningstar· 21 hours ago

      ...TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an...